The effect of electroanalgesia on relieving the pain of peripheral poly neuropathy in patients with type II diabetes
Not Applicable
Completed
- Conditions
- dibetic polyneuropathy.Diabetic polyneuropathy
- Registration Number
- IRCT201103176083N1
- Lead Sponsor
- Research center, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 39
Inclusion Criteria
pain due to neuropathy in diabetic patients
pain Excepts due to neuropathy in diabetic patients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: befor treatment, aftre treatment. Method of measurement: visual analog scale(VAS).
- Secondary Outcome Measures
Name Time Method Pain. Timepoint: pain. Method of measurement: visual Analog Scale(VAS).
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie electroanalgesia's analgesic effects in diabetic polyneuropathy?
How does electroanalgesia compare to gabapentinoids in managing type II diabetic peripheral neuropathy pain?
Are there specific biomarkers that predict electroanalgesia response in MTAP-loss associated diabetic polyneuropathy?
What adverse events are associated with electroanalgesia treatment in diabetic patients with peripheral neuropathy?
What combination therapies show synergistic effects with electroanalgesia for diabetic peripheral neuropathy management?